In an attempt to understand the signaling pathway mediating redox-induced apoptosis, we cloned SAG, an evolutionarily conserved zinc RING ®nger gene that, when overexpressed, protects cells from apoptosis induced by redox agents. Here we report functional characterization of SAG by the use of yeast genetics approach. Targeted disruption of ySAG, yeast homolog of human SAG, and subsequent tetrad analysis revealed that ySAG is required for yeast viability. Complementation experiment showed that the lethal phenotype induced by the ySAG deletion is fully rescued by wildtype SAG, but not by several hSAG mutants. Complementation experiment has also con®rmed that ySAG is essential for normal vegetative growth, rather than being required for sporulation. Furthermore, cell death induced by SAG deletion was accompanied by cell enlargement and abnormal cell cycle pro®ling with an increased DNA content. Importantly, SAG was found to be the second family member of Rbx (RING box protein) or ROC (Regulator of cullins) or Hrt that is a component of SCF E3 ubiquitin ligase. Indeed, like ROC1/Rbx1/Hrt1, SAG binds to Cul1 and SAG-Cul1 complex has ubiquitin ligase activity to promote poly-ubiquitination of E2/ Cdc34. This ligase activity is required for complementation of death phenotype induced by ySAG disruption. Finally, chip pro®ling of the entire yeast genome revealed induction of several G1/S as well as G2/M checkpoint control genes upon SAG withdrawal. Thus, SAG appears to control cell cycle progression in yeast by promoting ubiquitination and degradation of cell cycle regulatory proteins.
In an attempt to understand the signaling pathway mediating redox-induced apoptosis, we cloned SAG, an evolutionarily conserved zinc RING ®nger gene that, when overexpressed, protects cells from apoptosis induced by redox agents. Here we report functional characterization of SAG by the use of yeast genetics approach. Targeted disruption of ySAG, yeast homolog of human SAG, and subsequent tetrad analysis revealed that ySAG is required for yeast viability. Complementation experiment showed that the lethal phenotype induced by the ySAG deletion is fully rescued by wildtype SAG, but not by several hSAG mutants. Complementation experiment has also con®rmed that ySAG is essential for normal vegetative growth, rather than being required for sporulation. Furthermore, cell death induced by SAG deletion was accompanied by cell enlargement and abnormal cell cycle pro®ling with an increased DNA content. Importantly, SAG was found to be the second family member of Rbx (RING box protein) or ROC (Regulator of cullins) or Hrt that is a component of SCF E3 ubiquitin ligase. Indeed, like ROC1/Rbx1/Hrt1, SAG binds to Cul1 and SAG-Cul1 complex has ubiquitin ligase activity to promote poly-ubiquitination of E2/ Cdc34. This ligase activity is required for complementation of death phenotype induced by ySAG disruption. Finally, chip pro®ling of the entire yeast genome revealed induction of several G1/S as well as G2/M checkpointIntroduction Apoptosis (programmed cell death) is a genetically programmed active process for maintaining homeostasis under physiological conditions and for responding to various stimuli (Thompson, 1995; Vaux, 1993) . This form of cell death is characterized by cell membrane blebbing, cytoplasmic shrinkage, nuclear chromatin condensation and DNA fragmentation (Wyllie et al., 1980) . Apoptosis can be initiated in various cells by a wide variety of physical, chemical, and biological stimuli including diverse anti-cancer drugs, oxidative DNA damage reagents and cytokines (Kroemer, 1997; Thompson, 1995; Vaux and Strasser, 1996; White, 1996) . One of the common apoptosis inducers are reactive oxygen species (ROS), including superoxide anion, hydrogen peroxide, hydroxyl radical, and organic peroxides that are produced during normal respiratory processes or after oxidative insults, such as exposure to irradiation, UV, and chemicals (Sun, 1990) . Due to their non-speci®city and short half-life, it is believed that ROS induce apoptosis through an indirect mechanism by modifying cellular redoxsensitive molecules, such as p53 and NF-kB, that are directly involved in apoptosis regulation (Beg and Baltimore, 1996; Mayo et al., 1997; Sun et al., 1997; Sun and Oberley, 1996) .
Many genes are involved in this well-coordinated but complicated apoptotic process. In general, they can be divided into two classes: pro-apoptosis genes that induce apoptosis and anti-apoptosis genes that inhibit apoptosis. The balance between the activities of these two classes of genes determines the life or death of the cell (Peter et al., 1997; Steller, 1995) . The process of apoptosis can be divided into three distinct phases: initiation, eector and degradation (Kroemer et al., 1995) . Genes involved in the initiation phase of apoptosis, are those responsive to growth factor withdrawal (Bazenet et al., 1998) or DNA damage (e.g. p53), or the genes encoding ligands and their receptors (e.g. TNF/TNFR; Fas/Fas ligand) (for review, see Ashkenazi and Dixit, 1998; Baker and Reddy, 1998; Dragovich et al., 1998; Evan and Littlewood, 1998; Ko and Prives, 1996; Nagata, 1997) . At the execution phase of apoptosis the genes encoding caspases, a group of cysteine proteases play a key role (Nunez et al., 1998; Thornberry and Lazebnik, 1998) , functioning as initiator, ampli®er and executor (Fraser and Evan, 1996; Salvesen and Dixit, 1997) , and leading to committed apoptosis. Also involved in this phase are the genes encoding Bcl-2 family members that regulate apoptosis both positively and negatively (Kroemer, 1997; Reed, 1997 Reed, , 1998 . At the degradation phase of apoptosis, proteins that serve as substrates of caspases are degraded, resulting in the apoptotic appearance of cells (Cryns and Yuan, 1998) .
We have recently found that 1,10-phenanthroline (OP), a metal chelator and redox sensitive agent, is a potent p53 activator. It activates p53 transactivation activity, followed by induction of expression of several p53 target genes, including p21, Mdm2, and Bax . Activation of p53 leads to apoptotic cell death . In an attempt to identify genes that mediate OP-induced apoptosis, we employed dierential display with limited sets of primers and identi®ed two OP-inducible genes, glutathione synthetase (GSS) and sensitive to apoptosis gene (SAG). Both genes appear to protect, rather than to induce apoptosis Sun, 1997) . To further understand SAG function, we employed a yeast genetic approach by taking advantage of the fact that SAG is evolutionarily conserved between yeast Saccharomyces Cerevisiae and human. We report here that SAG is a yeast growth essential gene involved in cell cycle regulation and E3 ubiquitin ligase activity is required for growth. In addition, we have identi®ed several cell cycle control genes induced in response to SAG withdrawal.
Results

ySAG disruption is lethal
Targeted disruption of ySAG was ®rst carried out in diploid Y21 cells using a kanamycin resistance cassette generated from the pFA6-KanMX4 plasmid DNA by a PCR-assisted method, followed by transformation and G418 selection. The ySAG locus from drug resistant clones, as well as from wildtype cells, was PCR ampli®ed to identify knockouts. Based upon primer design, the wildtype ySAG gene should give rise to a 0.35 kb fragment, whereas the knockout allele should yield a 1.5 kb fragment. As shown in Figure 1 (left panel), wildtype cells generated exclusively the expected 0.35 kb fragment (lane 1), while all G418-resistant clones gave rise to both 0.35 kb and 1.5 kb fragments (e.g., lane 2), indicating that heterozygous mutants were produced. A similar knock-out experiment was conducted with haploid yeast cells (InvSC1 from InVitrogen). However, no G418-resistant clone could be obtained from these eorts. The failure to isolate such haploid ySAG::kan deletion mutants suggested the possibility that ySAG may be essential for growth. To con®rm this, twelve heterozygous knockout clones (ySAG/ySAG::kan) were sporulated and dissected to determine if ySAG::kan haploids were viable. Two of the tetrads from each clone should contain wildtype ySAG, while the other two should contain ySAG::kan. As a control, 14 wildtype Y21 clones were also sporulated and dissected. As shown in Table 1 , for all 12 heterozygotes dissected, only two out of four spores grew and in every case, the surviving colonies were sensitive to G418, indicating that they carried the wildtype ySAGgene. Figure 1 (middle and right panels) shows an example where four surviving haploids from two independent tetrads dissected from heterozygous clones (positions 3 ± 6) were grown on a YPD plate, along with parental heterozygous clone (position 1) and wildtype Y21 cells (position 2). None of the strains exhibited growth on the YPD+G418 plate, except the parental heterozygous clone that contains in one allele a kan cassette in the place of ySAG locus. In addition, all of the surviving haploids were con®rmed by PCR to contain the wildtype ySAG gene (not shown). These results clearly demonstrated that the ySAG knockout is lethal.
hSAG, but not its mutants rescues death phenotype induced by ySAG deletion If ySAG is functionally homologous to human hSAG, then hSAG should complement the ySAG knockout allele. We addressed this issue by transforming a yeast plasmid expressing hSAG (carrying a tryptophan selectable marker) into heterozygous ySAG knockout cells. Transformants were selected on tryptophanminus media and hSAG expression was con®rmed by Western blot analysis (not shown). hSAG-expressing clones were then sporulated and tetrads were dissected as above. If hSAG can rescue the ySAG::kan cells, then up to four haploids dissected from each tetrad will be recovered, displaying three types of haploid: wildtype, wildtype+hSAG plasmid and ySAG::kan+hSAG plasmid. Accordingly, colonies resulting from viable spores were evaluated for growth on YPD alone, YPD+G418, and YPD-minus tryptophan. Survivors were also analysed by PCR ampli®cation of the ySAG Table 1 . In every case, a viable colony containing the ySAG::kan allele also carried the hSAG plasmid, clearly demonstrating that ySAG and hSAG are functional homologs. SAG contains an evolutionarily conserved RING ®nger domain at its C-terminus. To determine whether the RING ®nger domain (C3H2C3) is required for hSAG rescuing activity, we generated two double mutants: SAG-MM10 (H82K/H85K) that disrupts both RINGs, and SAG-MM14 (C99S/C102S) that disrupts the second RING motif . The same type of complementation experiment described above was performed with these mutants. There were only two viable colonies from every tetrads dissected. PCR analysis revealed that the viable haploid contains the wildtype allele (Table 1) . The results showed that SAG mutants were unable to complement the death phenotype, indicating a requirement of the RING ®nger domain for SAG activity. To dierentiate metal binding/lipid peroxidation inhibitory activity of SAG Swaroop et al., 1999) from the activity required for growth, we generated another SAG double mutant, MM3 (C50S/ C53S) that retained wildtype activity in inhibition of copper ion-induced lipid peroxidation . In the same rescue experiment, MM3 failed to complement SAG-deletion induced cell death, as demonstrated by only two viable colonies from every tetrads dissected (Table 1) . The results indicated a dissociation of these two activities.
ySAG is essential for growth, but not for germination To determine if ySAG is required for normal growth or simply for germination, we cloned hSAG into a yeast expression vector with a URA3 selectable marker. The hSAG-URA plasmid was then tranformed into heterozygous ySAG knockout cells, and transformants were selected on URA-minus plates. Clones expressing hSAG (measured by Western blot analysis, not shown) were sporulated and tetrads dissected. Viable colonies were then screened on plates containing either YPD alone, or YPD+G418, or YPD+5-FOA that was used to select against cells expressing the URA3 gene (Boeke et al., 1984) . As shown in Figure 2 , the hSAG-URA3 plasmid complemented the ySAG::kan allele, as all four haploids from four individual tetrads showed viability ( Figure 2 , panel II, 1A to 4D). When grown on YPD+G418 plates (panel III), two haploids from each tetrad were nonviable (1A, 1D; 2C, 2D; 3A, 3B; and 4B, 4D), indicating that they contain the wildtype ySAG gene. Two other haploids from each of the tetrads (1B, 1C; 2A, 2B; 3C, 3D; and 4A, 4C) survived, indicating they contained ySAG::kan allele. When these latter colonies were grown on YPD+5-FOA plates (panel IV), which selects against URA3 plasmidcontaining cells, all failed to grow. Furthermore, growth on 5-FOA could be restored if wildtype hSAG, but not its three double mutants, were present on a second plasmid (with Trp selectable marker) that did not contain URA3 (data not shown). Likewise, the clone P (parental ySAG/ySAG::kan+hSAG-Ura) grew in YPD and YPD+G418, but not in YPD+FOA plate, the clone W (wildtype Y21) grew in YPD and YPD+FOA, but not in YPD+G418, whereas the Figure 2 hSAG rescues ySAG knockout phenotype and ySAG is essential for growth. Heterozygous ySAG knockout cells were transformed with a hSAG-expressing vector containing URA as a selectable marker. Transformants were then selected on URA minus plate and clones expressing hSAG (measured by Western blot) were sporulated. Four independent tetrads were dissected. The position of each haploid, along with parental cells is presented in Panel I. P stands for parental ySAG/ySAG::Kan+h-SAG-URA; W stands for wildtype Y21 cells, and K stands for heterozygous ySAG knockout (ySAG/ySAG::Kan). 1A to 4D are individual haploids. Yeast cells were grown in YPD plate (panel II), or in YPD+G418 plate to select for ySAG::Kan allele (panel III); or in YPD+FOA plate to select against hSAG-URA plasmid (panel IV)
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Yeast growth requires SAG/ROC/Rbx/Hrt M Swaroop et al clone K (ySAG/ySAG::kan) grew in all three plates ( Figure 2 ). Taken together, these results indicate that ySAG is essential for normal vegetative growth and not simply for sporulation.
Cell death by SAG deletion is accompanied with cell enlargement and abnormal cell cycle profile
To determine the nature of cell death caused by the SAG deletion, we compared the growth rate of haploid wildtype and K/O cells, both containing an URA-hSAG plasmid in the presence of 5-FOA for 0, 6, 16, 24, and 48 h. Figure 3 showed that the expression of hSAG protein as monitored by Western blot decreases 6 h post 5-FOA treatment, and is absent after 16 h and thereafter (middle panel). It is noteworthy that endogenous ySAG in wildtype cells was undetectable using our antibody. Concomitant with the loss of hSAG expression is the ®nding that K/O cells stopped growing (top panel) and were not viable when re-plated on YPD plate (bottom panel), whereas wildtype cells continued to grow (top) and remain viable up to 48 h (bottom), regardless of hSAG expression.
We also observed a change in cell morphology after 5-FOA treatment. As shown in Figure 4 , under light microscopy, a small portion of cells becomes enlarged in both wildtype and K/O groups 16 h post treatment. Both population of enlarged cells and the size of cell increase with time in K/O group. At the 48 h time point, cell numbers are signi®cant less in K/O group than that in wildtype group (also see Figure 3 , top panel) and the cell population consists of mainly enlarged cells. In contrast, the population of enlarged cells continues to decrease and disappear as the incubation time increase to 24 h or 48 h in wildtype group. It appears that the mild enlargement of cells size at 16 h time point re¯ects the 5-FOA toxicity, whereas further enlargement is causally related to SAG deletion.
We then performed¯uorescence-activated cell sorting (FACS) analysis for cell cycle pro®ling. An aliquot Figure 3 Growth rate of WT and K/O cells after exposure to 5-FOA: An overnight saturated culture was diluted into fresh SDTrp media to an OD 600 between 0.2 ± 0.4 in the presence of 5-FOA (1 mg/ml) for various times. At each time point, one aliquot of culture was counted for cell number to determine the growth rate (top panel), the second aliquot of cells was lysed and subjected to Western blot analysis (middle panel), and third aliquot of cells was re-plated in YPD plate and grown at 308C for 3 days (bottom panel)
Yeast growth requires SAG/ROC/Rbx/Hrt M Swaroop et al of the same culture used in morphological analysis was subjected to FACS analysis. As also shown in Figure 4 , without 5-FOA treatment, both wildtype and K/O cells are predominantly in G1 phase, as judged by their haploid DNA content (marked C for 1N) with a minor population at G2/M (marked G for 2N). With 5-FOA treatment, wildtype cells proceed through the cell cycle normally as shown by 1N and 2N peaks, except at 48 h in which a small portion of 4N cells is seen (marked F for 4N). In a striking contrast, K/O cells showed an abnormal FACS pro®le appearing at 6 h post treatment. A reproducibly broader distribution of¯uores-cence intensities was seen, with the peak shifting to the right (higher N number) as incubation time with 5-FOA increases. This FACS pro®le shifting was accompanied with morphological enlargement of cells. The results suggested an abnormality either in chromosome fragmentation or other alterations in Figure 4 Cell enlargement and abnormal cell cycle pro®le during ySAG-deletion induced cell death. Overnight saturated cultures were diluted and grown in the presence of 5-FOA, as described in Figure 3 legend. At various time points, cultures were taken either for morphological observation by light microscopy (X200), or for FACS analysis, as described in Materials and methods
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Yeast growth requires SAG/ROC/Rbx/Hrt M Swaroop et al chromosome structure, resulting from the deletion of the ySAG gene.
Like ROC1, SAG binds to Cul1
While this manuscript was in its late stage of preparation, several groups have reported the cloning and characterization of ROC1 (regulator of cullins), Rbx1 (RING box) or Hrt1 that either binds to cullins or VHL tumor suppressor gene product or SCF complex to form important E3 ubiquitin ligase complex Ohta et al., 1999; Seol et al., 1999; Skowyra et al., 1999; Tan et al., 1999; Tyers and Willems, 1999) . By direct sequencing comparison, SAG turns out to be the second member of this ROC/Rbx/Hrt family (ROC2/Rbx2/Hrt2). To examine whether SAG or its RING-disrupted mutants bind to Cul1, we co-transfected Cul1 with¯ag-tagged SAG or SAG mutants or the vector control. Cell lysates were immunoprecipitated with¯ag-tag antibody (F) or HA-tag antibody (H) as a control. The immunoprecipitates were subjected to Western analysis with anti-Cul1 antibody or¯ag-tag antibody (for SAG). As shown in Figure 5A , the top panel, Cul1 was detected when¯ag-tag antibody was used in the pull-down assay (lanes 2, 4, 6, 8), but not when HA-tag antibody was used (lanes 1, 3, 5, 7). Wildtype SAG (lane 2), as well as three SAG mutants (lanes 4, 6, 8), but not the vector control (lane 10), binds to Cul1. No signi®cant dierence in Cul1 binding was observed between wildtype and mutants. It is worthy noting that due to a low expression of SAG mutants, an excess of cell lysates were used from mutant SAG transfectants in the pull-down assay to achieve a relatively equal amount of SAG protein (bottom panel).
SAG-Cul1 complex has ubiquitin ligase activity and ligase activity of SAG is required for the rescue of yeast death phenotype
We have shown that target disruption of ySAG is lethal and this lethality could be rescued by wildtype hSAG, but not by three SAG mutants. We next examined potential correlation of this growth-essential biological activity with ubiquitin ligase activity. Cul1 was cotransfected with HA-tagged wildtype SAG or three SAG mutants, followed by 35 S-Met labeling. Cell lysates were immunoprecipitated with HA-tag antibody. A small aliquot of the pull-down samples was subjected to gel electrophoresis followed by autoradiography. Again, excess amount of cell lysates was used in SAG mutants than the wildtype to achieve a similar level of SAG-Cul1 protein ( Figure 5B) . A same proportion of cell lysates that showed similar level of SAG-Cul1 expression was pulled down by HA-tag antibody followed by E3 ubiquitin ligase activity assay. As shown in Figure 5C , in the absence of either Yeast chip profiling for genes responsive to SAG withdrawal
As shown in Figure 4 , SAG withdrawal induced cell enlargement and a broad distribution of¯uorescence intensities with an increased DNA content. This suggests that SAG may also be involved in regulation of other phases of the cell cycle in addition to G1?S progression, as previously reported . To identify genes that responded to SAG withdrawal, Aymetric GeneChip 1 technology, capable of detecting expression of all mRNAs encoded in entire yeast genome, was employed. Haploid SAG knockout cells supplemented with Ura-plasmid expressing hSAG and its wildtype control were treated with 5-FOA for 0, 12, 16 h (exogenous SAG expression was completely shut down at 12 h and thereafter, Figure 3 and data not shown), followed by total RNA isolation and chip hybridization. The mRNA pro®ling showed that expression of *75% of the yeast genome (about 4900 ORF out of 6593 ORF in total) was detected in each group of samples. Yeast SAG was detected only in wildtype cells, but not in knockout cells, con®rming the ySAG gene is truly disrupted. Compared to the untreated control, the genes, whose expressions were either induced or repressed for twofold or more at both treated time-points, were identi®ed. The potential 5-FOA responsive genes, found in both wildtype and K/ O groups after treatment, were excluded for further analysis. A total of 282 genes that appears to be SAGresponsive was identi®ed in K/O cells and was then analysed using the MIPS yeast genome computer software (http://www.mips.biochem.mpg). Particular attention was paid to the genes being classi®ed under category of cell cycle control and mitosis. Eleven such genes were identi®ed and all of them are induced upon SAG withdrawal (Table 2) . These eleven genes were also searched for in an independent experiment in which K/O cells were treated with 5-FOA for 24 h. Ten out of 11 showed a more than twofold induction (Table 2) . These eleven SAG-responsive genes can be sub-divided into the genes that (1) control G1?S progression such as CLG1, CDC53, TFS1, and GIF1; (2) control G2?M progression and mitotic exit such as BUB1, MAD2, CDC20, and MCD1. To verify chip expression data, six out of these 11 genes were analysed by RT ± PCR and a 100% agreement between two assays was achieved (Figure 6 ). Thus, consistent with our FACS analysis, these results suggest that in addition to be involved in controlling G?S progression, SAG-SCF complex may also involved in controlling other phases of cell cycle.
We have also searched 15 previously identi®ed candidate upstream regulatory elements frequently seen in the 5'-¯anking region of cell cycle regulatory genes (Cho et al., 1998) for the presence in the 1000 bp upstream of the translational start site of every gene listed in Table 2 . Three hits (TFS1, MCD1, and CTF8) were identi®ed to contain consensus sequence of AACGCG, which was found in the late G1 gene promoter with a frequency of 51% (Cho et al., 1998) . The other two late G1 related consensus sequences, ACGCTNA, and ACGCGT, were found in the promoter of BUB1, GIF1 and TFS1, MCD1, respectively. In addition, two mitosis related consensus sequences, AAACCC and ACTCTC were identi®ed in the promoter of CLG1, CDC20 and MAD2, MCD1, respectively. The results may imply that the transcription factors that binds to these sites might be the cellular targets of SAG-SCF complex. Withdrawal of SAG inhibits their degradation, followed by induction of expression of these genes.
Discussion
We have shown here that the yeast homolog of hSAG, a redox sensitive, apoptosis protective gene Swaroop et al., 1999) , is growth essential and required for yeast viability. We also showed that the lethality induced by a ySAG deletion could be fully complemented by human SAG, indicating conservation of function. Two RING motif-disrupted mutants, G1 factor needed for normal G1 phase 2.5 2.4 3.6 G1 regulation YGR129W (SYF2) Synthetic lethal with Cdc40 2.6 2.3 2.9 S/G2 control (Boger Nadjar et al., 1998) YGR188C (BUB1) Ser/thr protein kinase 2.0 2.0 2.2 G2/M checkpoint control (Farr and Hoyt, 1998) YJL030W (MAD2) Spindle-assembly checkpoint protein 2.5 2.8 3.5 Mitosis (Li and Benezra, 1996) (Thiele et al., 1986) . In budding yeast, it is known that there is only one member of the ySAG/yROC/yRbx/Hrt family. Targeted disruption of this gene results in cell death that can be fully rescued by ROC1/Rbx1 Ohta et al., 1999) or ySAG (this report) or ROC2, an N-terminal truncated SAG, as reported (Ohta et al., 1999) . Since both ROC1/Rbx1/Hrt1 and SAG has ubiquitin ligase activity when complexed with SCF component, it is likely that SAG/ROC/Rbx/Hrt regulates cell cycle through ubiquitin/proteolysis pathway. Ubiquitin-dependent proteolysis by the proteasome plays an essential role in a number of key biological processes, including cell cycle regulation (King et al., 1996; Maniatis, 1999) . During the cell cycle, protein degradation is required for the transition from G1 to S phase, sister chromatid separation in anaphase and the exit from mitosis (King et al., 1996) . The E3 ubiquitin ligase involved in promoting G1?S transition is referred to SCF complex, consisting of Skp1, Cdc53/cullin, F box proteins (Cdc4, Grr1, etc) King et al., 1996; Skowyra et al., 1997) . Through F-box protein Cdc4, SCF promotes ubiquitination and degradation of SIC1, a negative regulator of G1 progression, leading to activation of Cdc28P/cyclin B that trigger the initiation of DNA synthesis Verma et al., 1997) . On the other hand, through F box protein Grr1, SCF induces ubiquitination of G1 cyclin CLN1/2 to limit their accumulation (Deshaies et al., 1995; Hadwiger et al., 1989) . Thus, as a newly identi®ed activating component of SCF ubiquitin ligase, SAG/ROC/Rbx/ Hrt could promote G1?S progression Tyers and Willems, 1999) . Indeed, we showed here that like ROC1, SAG as well as its mutants binds to Cul1. When complexed with Cul1, only wildtype SAG, but not its SAG mutants have E3 ubiquitin ligase activity. Decreased Cul1 binding and reduced E3 ubiquitin ligase activity was recently reported in some of ROC1 single or double mutants . Since all three SAG double mutants failed to rescue death phenotype induced by ySAG disruption and all of them have lost E3 ubiquitin ligase activity, we concluded that E3 ubiquitin ligase activity is required for yeast growth.
In addition to the well-known function of SAG/ ROC/Rbx/Hrt-SCF complex in promoting G1?S progression, the complex may also play a role in controlling other phases of cell cycle. We showed a morphological cell enlargement and a broad distribution of¯uorescence intensities with an increased DNA content in SAG knockout cells (Figure 4) . Several recent ®ndings also support this notion: (1) Xenopus Cdc34, an E2 that binds to SAG/ROC/Rbx/Hrt Ohta et al., 1999; Seol et al., 1999; Skowyra et al., 1999; Tan et al., 1999; Tyers and Willems, 1999) promoted degradation of Wee1 (Michael and Newport, 1998), a key G2/M negative regulator (McGowan and Russell, 1993; Parker and Piwnica Worms, 1992) ; (2) SCF components, Skp1 and Cul1 were localized to the centrosome and regulated the centrosome duplication cycle in mammalian cells (Freed et al., 1999) ; and (3) Cdc4, an F-box protein in SCF complex was required for the onset of S phase as well as anaphase in Saccharomyces cerevisiae (Goh and Surana, 1999) .
To identify genes that are responsible for or associated with these phenomena, we performed chip pro®ling of entire yeast genome and identi®ed 11 cell cycle controlling genes, uniquely induced in knockout cells upon SAG withdrawal. Among genes that are involved in G1?S progression, Cul1 is a SAG/ROC binding protein and a component of E3 SCF complex required for SIC-1 degradation Ohta et al., 1999; Willems et al., 1996) . CLG1 is a cyclin-like protein that interacts with Pho85p (Matsumoto and Wickner, 1993) , a Ser/Thr kinase involved in induction of G1?S progression (Espinoza et al., 1994; Levine et al., 1995) . TFS1 is a suppressor of CDC25 mutations (Robinson and Tatchell, 1991) . It is known that CDC25 is a GDP/ GTP exchange factor for Ras (a Ras activator) and temperature-sensitive CDC25 mutants arrest at G1 (Iida and Yahara, 1984; Jones et al., 1991) . Finally, GIF1 is a G1 factor needed for normal G1 phase. Induction of these G1 promoting genes may re¯ect a cellular response to G1 arrest resulting from the accumulation of SIC1 upon SAG withdrawal. Potential involvement of SAG in G2/M control was suggested by induction of several checkpoint control genes. BUB1 and MAD2 are two well-known spindle-assembly checkpoint control proteins in budding yeast required for normal mitotic timing and exit from mitosis (Farr and Hoyt, 1998; Gorbsky, 1997; Li and Benezra, 1996; Murray, 1992) . In addition, CDC20, a component of anaphase promoting complex (APC) (Shirayama et al., 1998; Visintin et al., 1997) controlling cell division/mitotic exit is also induced. Other induced genes that control chromosome segregation and morphology include GLC8 and MCD1. Induction of these G2/M negative control genes may imply that SAG is involved/required in degradation of a group of proteins/transcription factors that positively regulates expression of these genes to ensure a normal transition of G2/M. Although chip pro®ling did not provide direct targets for SAG-mediated degradation, the promoter analysis of these genes induced by SAG withdrawal may provide a clue. The transcription factors/co-activators that binds to the consensus sequences such as AACGCG, AAACCC, or ACTCTC (see Results section) might be potential cellular targets of SAG-SCF E3 ubiquitin ligase. It is also interesting to note that Upl1, a protease speci®c to deconjugate protein from yeast ubiquitinlike protein, SUMO-1/Smt3, but not from ubiquitin (Li and Hochstrasser, 1999) share some phenotypic similarities with ySAG. First of all, disruption of either gene is lethal but can be rescued by their human homologs. Second, cells became enlarged upon withdrawal of either gene, and thirdly, withdrawal of either gene showed a similar FACS pattern that is more broad and skewed to right with more DNA content (Li and Hochstrasser, 1999; and this report) . These observations indicate that the ligase/protease involved in either conjugation or deconjugation of proteins during proteolysis plays an important role in precise regulation of cell cycle progression.
We have previously shown that SAG, through inhibition of cytochrome c release and caspase activation, protects cells from apoptosis induced by redox compounds and this protection requires the RING ®nger domain Sun, 1999; Swaroop et al., 1999) . SAG is also shown to be a component of E3 ubiquitin ligase involved in the degradation of many biological important molecules including IkB Ohta et al., 1999; Skowyra et al., 1999; Tan et al., 1999) . It is possible that anti-apopotosis activity of SAG/ROC/Rbx can also be achieved through ubiquitination and degradation of IkB, an inhibitor of NF-kB (Ohta et al., 1999; Tan et al., 1999) , leading to activation of apoptosis inhibitor, NF-kB (Beg and Baltimore, 1996; Mayo et al., 1997; Van Antwerp et al., 1996 , 1998 Wang et al., 1996) . This hypothesis is being tested currently in our laboratory.
In summary, we have simultaneously and independently identi®ed that ySAG/ROC/Rbx/Hrt is a growth essential gene and that the lethal phenotype induced by gene targeting can be rescued by human SAG, consistent to the ®nding reported recently by others Ohta et al., 1999) . In addition, we have shown here that SAG is required for cell growth, but not required for sporulation/germination using 5-FOA counter-selection. We also showed ySAG disruption induces cell enlargement and abnormal cell cycle pro®le, suggesting that in addition to being involved in G1?S transition, SAG may also be involved in G2/M transition. This notion is supported by chip pro®ling that identi®ed genes controlling both G1/S and G2/M are responsive to SAG withdrawal. Finally, using three SAG mutants either within the RING domain or outside of the RING domain, we de®ned that E3 ligase activity is required for SAG to maintain yeast growth.
Materials and methods
Yeast strains
The Saccharomyces cerevisiae strain utilized in this study were Y21 (a/a ura3-52/ura3-52 lys2-801/lys2-801 ade 2-101/ade 2-101 trp1-1D/trp1-1D).
Disruption of the ySAG gene
Gene disruption was carried out using kanamycin cassette generated from pFA6-KanMX4 plasmid as the template by a PCR-assisted method (Wach et al., 1994) . The primers used were SagKanMX4-5: 5'-TTCTCCAGTGGCAGAGAAC TTTAAAGAGAAATAGTTCAACCGTACGCTGCAGGT-CGAC-3' and SagKanMX4-3: 5'-ACCTCGGTATGATTT AAATGTTTACGGGCAATTCATTTTTATCGATGAATT-CGAGCTCG-3'. The primer SagKanMX4-5 consists of yeast SAG DNA sequence (ORF YOL133w, ATCC Accession number Z74876) immediately upstream of the initiation codon ATG (underlined) and the upstream kanamycin cassette sequence at its 3'-end. Primer SagKanMX4-3 consists of yeast SAG DNA sequence immediately downstream of the stop codon TGA (underlined) and the downstream kanamycin cassette sequence at its 3'-end. PCR was conducted for 5 cycles at 948C 1 min, 508C 1.5 min, 728C 2 min, followed by 25 cycles at 948C 1 min, 568C 1.5 min, 728C 2 min, followed by a 10 min extension at 728C. The resulting PCR product (1.5 kb) was gel-puri®ed using Qiaex II gel-puri®cation kit (Qiagen), and was used to transform the diploid yeast strain Y21 using the YEASTMAKER Transformation System (ClonTech Laboratory, Inc.) according to the manufacturer's instruction. Following transformation, yeast cells were grown in YPD media (Difco) containing G418 (200 mg/ml, BRL) to select transfectants containing the kanamycin cassette, which have had the yeast SAG disrupted/replaced by homologous recombination. Several G418-resistant clones were selected and assayed.
Yeast sporulation and dissection
The strains were inoculated into minimal potassium acetate sporulation media, supplemented with uracil, lysine, adenine and tryptophan (Kassir and Simchen, 1991) and grown at 308C for 7 days. Tetrads were dissected into four haploid osprings from each strain. For dissection, a clamp of cells from the sporulation plate was suspended in 100 ml of 1 M glycerol containing 0.5 mg/ml zymolase T20. After 30 min at 378C, the suspension was diluted with 800 ml sterile water and put on ice. A loop of suspension was struck across a YPD plate and examined under a Zeiss Tetrad microscope for tetrads. The glass microneedle was used to dissect tetrads from each strain.
hSAG complementation
The entire coding region of wildtype hSAG as well as three hSAG double mutants, generated previously was subcloned, respectively, into p414 (Trp marker, driven by glyceraldehyde-3-phosphate dehydrogenase promoter) for complementation, or p426 (Ura marker, driven by alcohol dehydrogenase promoter) for counter selection with 5-¯uoroorotic acid (5-FOA). The consructs were transformed into the heterozygous knockout strain (ySAG/ySAG::kan) by using the YEASTMAKER Transformation System (ClonTech Laboratory, Inc.), followed by tetrad dissection.
Western blot analysis
Expression of hSAG in yeast was examined by Western blot using hSAG antibody . Brie¯y, whole cell extracts were prepared by vortexing the yeast cells with glass beads as described previously (Printen and Sprague, 1994) in Oncogene Yeast growth requires SAG/ROC/Rbx/Hrt M Swaroop et al the presence of Urea/SDS lysis buer (8 M Urea, 5% SDS, 40 mM Tris-HCl pH 6.8, 0.1 mM EDTA, 1% b-mercaptoethanol), supplemented with protease inhibitors. Proteins were resolved on a 10 ± 20% SDS ± PAGE gel and transferred to a polyvinylidene di¯uoride membrane (Amersham, Arlington Hts, IL, USA) using a semi-dry transfer apparatus. Immunoblot was probed with rabbit anti-SAG antibody (1 : 5000), followed by horseradish-peroxidase-conjugated goat anti rabbit IgG antibody. Protein was detected with enhanced chemiluminiscence Western blotting detection reagents (Amersham).
FACS analysis
FACS analysis was performed as described (Sazer and Sherwood, 1990) . Brie¯y, yeast cells after 5-FOA treatment for various periods of time were ®xed in 70% ethanol, digested with RNase A at 378C for 2 h followed by staining with 4 mg/ml of propidium iodide. Flow cytometric determination of cellular DNA content was performed on a Coulter Elite ESP Cell Sorter (Beckman Coulter).
Transfection, metabolic labeling and extract preparation
Human 293T cells were grown in DMEM (Gibco BRL) containing10% heat inactivated FBS (Gibco BRL), and 1% antibiotic-gentamicin (Gibco BRL). Cells were co-transfected with pcDNA vectors expressing either HA-SAG or HA-SAG mutants with Cul1 (10 mg of the DNA construct per dish) using the standard calcium phosphate precipitation method. At 48 h post-transfection cells were washed with 10 ml PBS, starved for 30 min and then media was changed to include 100 mCi/ml Easy Tag Express-( 35 S) Protein labeling mix from NEN. After 2 h labeling, cells were harvested and cell pellet was resuspended in 0.2 ml of buer A (10 mM Tris-HCL pH 7.4, 10 mM NaCl, 0.5% NP40, 1 mM PMSF, 2 mg/ml antipain, 2 mg/ml leupeptin) and lysed by sonication. Equal volume of buer B (20 mM Tris-HCL pH 7.4, 1 M NaCl, 0.2% NP40, 1 mM PMSF, 2 mg/ml antipain, and 2 mg/ml leupeptin) was added and the resulting mixture was rocked for 60 min at 48C prior to centrifugation at 100 000 g at 48C, 60 min.
Immunoprecipitation
Extracts containing over-expressed HA-SAG and Cul1 were rocked with HA antibody (HA-7, Sigma) in the presence of protein agarose beads (40 ml, Upstate Biotechnology) for 1 h at 48C. The beads were then washed sequentially three times with 0.5 ml buer C (buer A and B mixed in equal volumes) and two times with buer D (25 mM Tris-HCl pH 7.4, 1 mM EDTA, 0.01% NP40, 10% glycerol, and 50 mM NaCl). Then 20 ml of SDS-loading buer was added and boiled for 3 min. Half the reaction was used for SDS ± PAGE followed by autoradiography.
Ubiquitin labeling and Ub ligation assay
Phosphorylation of PK-Ub (7 mg) (from Dr Pan (Tan et al., 1999) ), was carried out in a 20 ml reaction mixture containing 20 mM Tris-HCl pH 7.4, 12 mM MgCl 2 , 2 mM NaF, 50 mM NaCl, 25 mM ATP, 5 mCi of g 32 P-ATP, 0.1 mg/ml BSA, and 1 unit of cAMP kinase (Sigma). The reaction mixture was incubated at 378C for 30 min. Reaction was terminated by incubation at 708C for 3 min. The immunoprecipitated samples prepared as described above, was added to a Ub ligation reaction mixture (30 ml) that contained 50 mM TrisHCl, pH 7.4, 5 mM MgCl 2 , 2 mM NaF, 10 nM okadaic acid, 2 mM ATP, 0.6 mM DTT, 1 mg 32P ± Ub, 60 ng E1 (Aniti, UK) and 300 ng mCdc34 (from Dr Pan (Tan et al., 1999) ). The mixture was incubated at 378C for 1 h with constant shaking. The reaction mixture was then mixed with concentrated Laemmli loading buer, boiled for 3 min prior to 12.5% SDS ± PAGE analysis. The gel was dried and exposed to X-ray ®lm (Tan et al., 1999; Wu et al., 2000) .
Yeast RNA isolation, chip hybridization and RT ± PCR Yeast cultures were grown overnight in selection media, pelleted and resuspended at 0.2 ± 0.4 OD 600 in SD-ura minus media containing 1 mg/ml of 5-Fluoroorotic acid (5-FOA). Cells were pelleted at 0, 12, 16, and 24 h post treatment for RNA preparation. RNA was isolated by the FastRNA kit-RED (BIO101), according to manufacturer's recommendation. Aymetrix oligonucleotide arrays, capable of detecting the entire ORF of the yeast genome (Ye6100) were used for mRNA expression pro®ling (Lockhart et al., 1996; Wodicka et al., 1997) , as detailed previously . RNA abundance was determined based on the average of the dierences between perfect match and mismatch intensities for each probe family. Gene induction or repression was considered signi®cant if the change in average dierence intensity was above two-fold . The RNA samples prepared above was also subjected to RT ± PCR analysis using the SuperScript one-step RT ± PCR system from Gibco BRL. The primer used are, (1) for MAD2 (577 bp): MAD2-5' GTC ACAATCAATATCACTAAAG; MAD2-3' GCTGACCTGCGCACCAACT; (2) for TFS1 (670 bp): TFS1-5' ATGAACCAAGCAATAGACTTCG; TFS1-3' CTATTTCGTTTCCGCATAGAAG; (3) for CDC20 (954 bp): CDC20-5' GCCAGAAAGCTCTAGAGA-TAAG; CDC20-3' CCGATAGAGATATGACAATCA; (4) for CDC53 (963 bp): CDC53-5' ATGTCTGAGACTC-TGCCTAGATC; CDC53-3' GTCTCTGCGTATTAGTGC-GTAC; (5) for BUB1 (747 bp): BUB1-5' GTTCTACTGTA-CGAGGCTATG; BUB1-3' CGTTAGGAGCAGACTTAC-CAAC; and (6) for MCD1 (898 bp): MCD1-5' ATGGTTA-CAGAAAATCCTCAAC; MCD1-3' CGTATCTATATTG-CCTGCGGG.
Abbreviations
Cul1, cullin1; 5-FOA, 5-¯uoroorotic acid; GSS, glutathione synthetase; HA, hemagglutinin A epitope; OP, 1,10-phenanthroline; Rbx, RING box protein; ROC, regulator of cullins; ROS, reactive oxygen species; SAG, sensitive to apoptosis gene; SCF, Skp/cullin/F-box.
